Odyssey Therapeutics acquires Rahko

Financing and Partnerships

Jan 6

Written By Frances Benson

https://odysseytx.com/news/

2022

Frances Benson

Nimbus Therapeutics announces expansion of oral allosteric TYK2 inhibitor program

ADARx Pharmaceuticals appoints Dr. Hubert Chen as CMO